Infosys completes acquisition of Life Sciences Consulting and Technology Leader, BASE life science

2 Sep 2022 , 01:52 PM

Infosys has announced that it has completed the acquisition of BASE life science, a leading technology and consulting firm in the life sciences industry, in Europe. This follows the announcement the company made on July 13, 2022.

The acquisition assures Infosys’ commitment to help global life sciences companies realize business value from cloud-first digital platforms and data to speed-up clinical trials and scale drug development, positively impacting lives and achieving better health outcomes. 

BASE further expands Infosys’ footprint in the Nordics region and will bring domain experts with commercial, digital marketing, clinical, medical, regulatory, and quality knowhow. Supported by data science specialists’ team, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ability to bridge and integrate business logic and technology, driving insights for better health outcomes.

BASE, headquartered in Denmark is one of the fastest growing technology and consulting partners in the life sciences industry.

At around 1:55 PM, Infosys Ltd is currently trading at Rs1,457.50 per share down by Rs6.9 or 0.47% from its previous closing of Rs1,464.40 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]